JOHNSON & JOHNSON
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
JNJ$282.11+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated balance sheets
Johnson & Johnson and subsidiaries consolidated balance sheets
At December 31, 2023 and January 1, 2023
(Dollars in Millions Except Share and Per Share Amounts) (Note 1)
| 2023 | 2022 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Notes 1 and 2) | $21,859 | 12,889 |
| Marketable securities (Notes 1 and 2) | 1,068 | 9,392 |
| Accounts receivable trade, less allowances $166 (2022, $169) | 14,873 | 14,039 |
| Inventories (Notes 1 and 3) | 11,181 | 10,268 |
| Prepaid expenses and other receivables | 4,514 | 2,876 |
| Current assets of discontinued operations (Note 21) | — | 5,830 |
| Total current assets | 53,495 | 55,294 |
| Property, plant and equipment, net (Notes 1 and 4) | 19,898 | 17,982 |
| Intangible assets, net (Notes 1 and 5) | 34,175 | 38,489 |
| Goodwill (Notes 1 and 5) | 36,558 | 36,047 |
| Deferred taxes on income (Note 8) | 9,279 | 8,947 |
| Other assets | 14,153 | 9,212 |
| Noncurrent assets of discontinued operations (Note 21) | — | 21,407 |
| Total assets | $167,558 | 187,378 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | $3,451 | 12,756 |
| Accounts payable | 9,632 | 9,889 |
| Accrued liabilities | 10,212 | 10,719 |
| Accrued rebates, returns and promotions | 16,001 | 13,579 |
| Accrued compensation and employee related obligations | 3,993 | 3,049 |
| Accrued taxes on income (Note 8) | 2,993 | 2,220 |
| Current liabilities of discontinued operations (Note 21) | — | 3,590 |
| Total current liabilities | 46,282 | 55,802 |
| Long-term debt (Note 7) | 25,881 | 26,886 |
| Deferred taxes on income (Note 8) | 3,193 | 3,991 |
| Employee related obligations (Notes 9 and 10) | 7,149 | 6,542 |
| Long-term taxes payable (Note 1) | 2,881 | 4,306 |
| Other liabilities | 13,398 | 10,146 |
| Noncurrent liabilities of discontinued operations (Note 21) | — | 2,901 |
| Total liabilities | 98,784 | 110,574 |
| Commitments and Contingencies (Note 19) | ||
| Shareholders’ equity | ||
| Preferred stock — without par value (authorized and unissued 2,000,000 shares) | — | — |
| Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (12,527) | (12,967) |
| Retained earnings and Additional-paid-in-capital | 153,843 | 128,345 |
| Less: common stock held in treasury, at cost (Note 12) (712,765,000 shares and 506,246,000 shares) | 75,662 | 41,694 |
| Total shareholders’ equity | 68,774 | 76,804 |
| Total liabilities and shareholders’ equity | $167,558 | 187,378 |
44
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.